<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05610267</url>
  </required_header>
  <id_info>
    <org_study_id>T-GENVIH-002</org_study_id>
    <nct_id>NCT05610267</nct_id>
  </id_info>
  <brief_title>Gentrix® Surgical Matrix for Soft Tissue Reinforcement in Ventral Hernia Repair</brief_title>
  <official_title>A Retrospective Analysis of the Use of Gentrix® Surgical Matrix for Soft Tissue Reinforcement in Ventral Hernia Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Integra LifeSciences Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Integra LifeSciences Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to collect additional safety data and demonstrate the&#xD;
      performance of Integra Gentrix® Surgical Matrix for reinforcement of ventral hernia repairs.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Retrospective data will be collected and assessed for early post-operative surgical site&#xD;
      events and complications in the immediate post-operative period of 90 days.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">November 22, 2022</start_date>
  <completion_date type="Anticipated">April 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of post-operative complications requiring procedural intervention within 90 days post index procedure</measure>
    <time_frame>90 days</time_frame>
    <description>Percentage of subjects with a post-operative complications requiring procedural intervention within 90 days post index procedure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of early post-operative complications (Surgical Site Occurrences (SSOs)) within 90 days post index procedure</measure>
    <time_frame>90 days</time_frame>
    <description>Percentage of subjects with an early post-operative complications (Surgical Site Occurrences (SSOs)) within 90 days post index procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Surgical Site Infections (SSIs) Post index procedure</measure>
    <time_frame>90 days</time_frame>
    <description>Percentage of subjects with SSIs Post index procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of later post-operative complications after 90 days post index procedure</measure>
    <time_frame>1 year</time_frame>
    <description>Percentage of subjects with a later post-operative complications after 90 days post index procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of hernia recurrence confirmed by clinical assessment</measure>
    <time_frame>1 year</time_frame>
    <description>Percentage of subjects with a hernia recurrence confirmed by clinical assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of reoperation requirement due to index repair</measure>
    <time_frame>1 year</time_frame>
    <description>Percentage of subjects with a reoperation requirement due to index repair</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Average length of hospital stay (LOS) post index procedure (measured in days)</measure>
    <time_frame>90 days</time_frame>
    <description>Number of days between the surgery date and the hospital discharge</description>
  </other_outcome>
  <other_outcome>
    <measure>Rate of opioid usage following procedure determined by % of prescriptions filled and refilled</measure>
    <time_frame>90 days</time_frame>
    <description>Opioid usage will be evaluated based on the Concomitants medication</description>
  </other_outcome>
  <enrollment type="Actual">29</enrollment>
  <condition>Ventral Hernia</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Retrospective chart review</intervention_name>
    <description>The retrospective chart review will include the full consecutive series of patients between 22 years and 80 years old who underwent abdominal wall reconstruction for achart hernia with Integra Gentrix® Surgical Matrix during the time period between November 1, 2017, and present (90 days prior to the start of data collection).</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients between 22 years and 80 years old (inclusive) at time they underwent abdominal&#xD;
        wall reconstruction utilizing Gentrix® Surgical Matrix as a reinforcement graft during the&#xD;
        time period between November 1, 2017, and present (90 days prior to the start of the data&#xD;
        collection).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients between 22 years and 80 years old (inclusive) at time they underwent&#xD;
             abdominal wall reconstruction utilizing Gentrix® Surgical Matrix as a reinforcement&#xD;
             graft during the time period between November 1, 2017, and present (90 days prior to&#xD;
             the start of the data collection)..&#xD;
&#xD;
          2. Subject underwent abdominal wall reconstruction for a hernia(s) using Integra®&#xD;
             Gentrix® Surgical Matrix.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Subject has known allergy to porcine-derived products.&#xD;
&#xD;
          2. Subject required use of Gentrix® device and a second non-Gentrix surgical mesh in the&#xD;
             same plane or in different planes for single hernia e.g., Gentrix sublay and a&#xD;
             synthetic device in the onlay position.&#xD;
&#xD;
          3. Subject had active necrotizing fasciitis or any current known uncontrolled systemic&#xD;
             infection.&#xD;
&#xD;
          4. Subject had uncontrolled diabetes, defined as Hb1AC value &gt;7% within 12 weeks prior to&#xD;
             index procedure.&#xD;
&#xD;
          5. Subject has been diagnosed with cirrhosis and/or ascites.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adam Young, MD</last_name>
    <role>Study Director</role>
    <affiliation>Integra LifeSciences Corporation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Surgical Healing Arts Center</name>
      <address>
        <city>Fort Myers</city>
        <state>Florida</state>
        <zip>33912</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2022</verification_date>
  <study_first_submitted>November 2, 2022</study_first_submitted>
  <study_first_submitted_qc>November 2, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2022</study_first_posted>
  <last_update_submitted>December 16, 2022</last_update_submitted>
  <last_update_submitted_qc>December 16, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">December 19, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Ventral</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

